An increasing number of patients with osteoporosis of the type that occurs chronicaly in the elderly, and particulaly in elderly women have recently realized in our pain clinic.
We feel that it is important not only to treat pain in these patients, but also to follow up bone mass and prevent the loss of bone mass. To measure bone mass in patients with osteoporosis, we emploied the Microdensitometry (MD) method, and we examined change of bone mass in patients on long-term therapy with Gui-zhi-jia-shu-fu-tang.
In 15 patients given Gui-zhi-jia-shu-fu-tang, the initial bone mass data were: metacarpal index (MCI), 0.39±0.99; bone density (ΣGS/D), 2.07±0.36. Measurements performed after three, six, and nine months of treatment showed no difference or an increase from the initial values. At nine months, the MCI was 0.41±0.09 and the ΣGS/D was 2.15±0.31, showing a 2.4% and 4.4% increase, respectively. In addition, the severity of pain was reduced by treatment with Gui-zhi-jia-shu-fu-tang.
As an untreated control group, we selected 10 osteoporotic patients who have discontinued the treatment. Bone mass was measured by the MD method and the follow-up period was six months to one year (mean: 9.9 months). The initial MCI and ΣGS/D value were 0.40±0.07 and 2.26±0.41, respectively, and they were 0.36±0.05 and 1.99±0.37 after 10 months, showing a significant decrease.
The control group revealed a 10% decrease of bone mass over 10 months, while the group given Gui-zhi-jia-shu-fu-tang showed suppression of bone loss demonstrating the effect of this agent in maintaining and improving bone mass.
View full abstract